Tingkat Kepatuhan Pengobatan pada Pasien Prolanis Diabetes Melitus Tipe 2 di Klinik Jatisari Karawang Periode bulan Januari – Maret 2021
DOI:
https://doi.org/10.46799/jhs.v2i12.370Keywords:
diabetes melitus, tingkat kepatuhan, kuesioner morisky medication adherence scale 8 items (mmas-8)Abstract
Diabetes mellitus is a metabolic disease characterized by hyperglycemia that occurs due to defects in insulin secretion, insulin action or both. Half-life is very important, especially in long-term treatment in order to achieve therapeutic success. As in the Hadith narrated by Muslim. That every disease has a cure. Then the drugs used obediently will help the patient's condition get better. In the management of the disease, the role of the patient becomes very important, especially in terms of increasing adherence to therapy in order to achieve optimal blood glucose levels to prevent more severe complications. The purpose of this study was to describe the level of treatment of patients with diabetes mellitus prolanis at Jatisari Clinic in the period from January to April 2021. The type of research conducted an observational study using a descriptive method. Sampling using a total sampling technique with a sample of 99 patients. The primary data collection instrument used a Morisky Medication Adherence Scale 8 items (MMAA-8) questionnaire find the level of adherence therapy in Diabetes Mellitus patients. The results of the study found that the level of adherence to treatment in patients with diabetes mellitus prolanis at Jatisari Clinic according are "High Adherence" , “Medium Adherence”, and “ Low Adherence” with 33 patients (33.33%) , 43 patients (43.44%) and 23 patients (23.22%) respect ively
Published
Issue
Section
License
Copyright (c) 2021 Aliyana Aliyana, Meiti Rosmiati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.